TelyRx Holdings Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025
Cash & Equivalents	27	2.99
Cash & Short-Term Investments	27	2.99
Cash Growth	-	-
Accounts Receivable	0.74	0.46
Inventory	1.25	1.35
Other Current Assets	0.92	0.76
Total Current Assets	29.9	5.56
Net Property, Plant & Equipment	3.22	3.28
Other Intangible Assets	1.07	1.04
Total Assets	34.2	9.88
Accounts Payable	3.78	2.66
Accrued Expenses	3.56	3.79
Current Portion of Long-Term Debt	0.13	9.17
Current Portion of Leases	0.17	0.17
Unearned Revenue	0.04	0.04
Total Current Liabilities	7.67	15.82
Long-Term Debt	10.02	-
Long-Term Leases	2.49	2.53
Total Long-Term Liabilities	12.51	2.53
Total Liabilities	20.18	18.35
Additional Paid-in Capital	43.08	15.91
Retained Earnings	-29.06	-24.39
Shareholders' Equity	14.02	-8.47
Total Liabilities & Equity	34.2	9.88
Total Debt	12.8	11.87
Net Cash (Debt)	14.2	-8.88
Net Cash Growth	-	-
Net Cash Per Share	0.29	-0.83
Book Value	14.02	-8.47
Book Value Per Share	0.29	-0.79
Tangible Book Value	12.95	-9.51
Tangible Book Value Per Share	0.27	-0.89